Verona Pharma PLC Alpha and Beta Analysis
| VRNADelisted Stock | USD 86.00 2.00 2.38% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Verona Pharma PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Verona Pharma over a specified time horizon. Remember, high Verona Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Verona Pharma's market risk premium analysis include:
Beta 0.0854 | Alpha (0.29) | Risk 2.75 | Sharpe Ratio 0.11 | Expected Return 0.29 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Verona |
Verona Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Verona Pharma market risk premium is the additional return an investor will receive from holding Verona Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Verona Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Verona Pharma's performance over market.| α | -0.29 | β | 0.09 |
Verona Pharma Fundamentals Vs Peers
Comparing Verona Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Verona Pharma's direct or indirect competition across all of the common fundamentals between Verona Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Verona Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Verona Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Verona Pharma to competition |
| Fundamentals | Verona Pharma | Peer Average |
| Return On Equity | -0.36 | -0.31 |
| Return On Asset | -0.0668 | -0.14 |
| Profit Margin | (0.37) % | (1.27) % |
| Operating Margin | 0.13 % | (5.51) % |
| Current Valuation | 8.99 B | 16.62 B |
| Shares Outstanding | 84.98 M | 571.82 M |
| Shares Owned By Insiders | 4.88 % | 10.09 % |
Verona Pharma Opportunities
Verona Pharma Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Verona Pharma Assessing Valuation After Recent Share Price Movement | 09/09/2025 |
2 | Why Verona Pharma plc stock attracts HNW investors - Quarterly Earnings Report Safe Capital Growth Tips - newser.com | 09/29/2025 |
3 | Verona Pharma plc s Shareholders Authorizes the 10 Billion Acquisition of Verona Pharma plc Nasdaq Trading to Suspend | 10/08/2025 |
4 | Merck Completes 10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre | 10/13/2025 |
5 | Will Verona Pharma plc stock outperform energy sector in 2025 - Weekly Loss Report Free Expert Verified Stock Movement Alerts - nchmf.gov.vn | 10/20/2025 |
6 | Using data models to predict Verona Pharma plc Depositary Receipt stock movement - Trade Volume Report Risk Adjusted Swing Trade Ideas - newser.com | 10/24/2025 |
7 | JNJ vs. MRK Which Blue-Chip Pharma Stock Should Be in Your Portfolio | 10/27/2025 |
8 | Verona Pharma PLC American Depositary Share VRNA Shares Bought by Y Intercept Hong Kong Ltd | 10/28/2025 |
9 | MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down | 10/30/2025 |
10 | Can momentum traders help lift Verona Pharma plc Depositary Receipt - Market Performance Recap AI Driven Stock Price Forecasts - newser.com | 11/04/2025 |
About Verona Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Verona or other delisted stocks. Alpha measures the amount that position in Verona Pharma PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Verona Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Verona Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Verona Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Verona Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Verona Pharma. Please utilize our Beneish M Score to check the likelihood of Verona Pharma's management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Verona Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Verona Stock
If you are still planning to invest in Verona Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verona Pharma's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |